One Stop Shop for All Your Market Research Reports

Global Human Growth Hormone Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland. According to our (Global Info Research) latest study, the global Human Growth Hormone market size was valued at USD 4584.2 million in 2022 and is forecast to a readjusted size of USD 5735.9 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry. North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume. This report is a detailed and comprehensive analysis for global Human Growth Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Human Growth Hormone market size and forecasts, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2018-2029 Global Human Growth Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2018-2029 Global Human Growth Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2018-2029 Global Human Growth Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (Million IU), and ASP (USD/IU), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Human Growth Hormone To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Human Growth Hormone market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation Human Growth Hormone market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Powder Solvent Market segment by Application Growth Hormone Deficiency (GHD) Turner Syndrome Chronic Renal Insufficiency Prader Willi Syndrome Small for Gestational Age SHOX Deficiency Others Major players covered Novo Nordisk Pfizer Eli Lilly Merck Serono F. Hoffmann-La Roche Ferring Pharmaceuticals GeneScience Pharmaceuticals Ipsen LG Life Sciences Sandoz International Anhui Anke Biotechnology Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Human Growth Hormone product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Human Growth Hormone, with price, sales, revenue and global market share of Human Growth Hormone from 2018 to 2023. Chapter 3, the Human Growth Hormone competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Human Growth Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Growth Hormone market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of Human Growth Hormone. Chapter 14 and 15, to describe Human Growth Hormone sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Human Growth Hormone 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global Human Growth Hormone Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Powder 1.3.3 Solvent 1.4 Market Analysis by Application 1.4.1 Overview: Global Human Growth Hormone C
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 21988
Category
  • Pharmaceuticals and Healthcare
Published on 02-Jan
Number of Pages 102
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(59)